Learn More
Invitrogen™ CXCR7 Recombinant Rabbit Monoclonal Antibody (SN65-09)

Description
Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
Specifications
Specifications
| Antigen | CXCR7 |
| Applications | Western Blot |
| Classification | Recombinant Monoclonal |
| Clone | SN65-09 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | TBS with 0.05% BSA, 40% Glycerol and 0.05% sodium azide; pH 7.4 |
| Gene | Ackr3 |
| Gene Accession No. | O89039, P25106, P56485 |
| Gene Alias | ACKR3; Atypical chemokine receptor 3; AW541270; C Cmotif chemokine; C X C motif chemokine; CC motif chemokine; CCmotif chemokine; chemokine; chemokine (C-X-C motif) receptor 7; chemokine orphan receptor 1; Cmkor1; CXC; C-X-C chemokine receptor type 7; CXC motif chemokine; CXCR7; CXC-R7; CXCR-7; G protein-coupled receptor; GPR159; G-protein coupled receptor 159; G-protein coupled receptor RDC1 homolog; RDC1; RDC-1 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.